| Stage | DBD | % of rev | BRLT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $994M | 100.00% | $115M | 100.00% | DBD ×8.64 |
| Gross profit | $247M | 24.86% | $67M | 57.90% | BRLT +33.0pp |
| Operating income | $39M | 3.90% | $446,000 | 0.39% | DBD +3.5pp |
| Pre-tax income | $15M | 1.54% | $842,000 | 0.73% | DBD +0.8pp |
| Net income | $7M | 0.71% | $842,000 | 0.73% | 0.0pp |
| Stage | DBD | BRLT | Gap · A − B |
|---|---|---|---|
| Revenue | $994M100.00% | $115M100.00% | DBD ×8.64 |
| Gross profit | 24.86%$247M | 57.90%$67M | BRLT +33.0pp |
| Operating income | 3.90%$39M | 0.39%$446,000 | DBD +3.5pp |
| Pre-tax income | 1.54%$15M | 0.73%$842,000 | DBD +0.8pp |
| Net income |
| 0.71%$7M |
| 0.73%$842,000 |
| 0.0pp |